Discontinued — last reported Q3 '23
Humana Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) increased by 100.0% to $16.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 42.9%, from $28.00M to $16.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $32.00M | $34.00M | $29.00M | $29.00M | $29.00M | $28.00M | $28.00M | $8.00M | $16.00M |
| QoQ Change | — | +6.3% | -14.7% | +0.0% | +0.0% | -3.4% | +0.0% | -71.4% | +100.0% |
| YoY Change | — | — | -9.4% | -14.7% | — | -3.4% | -3.4% | -72.4% | -42.9% |